RxDoctor Payments Data

Roger Kilfoil

Foot & Ankle Surgery · Baldwin, NYNPI 1699157586

Payments from drug & device makers

$8,959in general payments, 2019–2025

Across 116 payments — averaging $77.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$2K
  • Kerecis Limited$1K
  • Stryker$863
  • Integra Lifesciences Corporation$717
  • Tactile Systems Technology Inc$614
  • Polaris Technology Solutions LLC$593
  • plus $3K from 23 others

What the payments were for

  • Travel & lodging$1,73419%
  • Food & beverage$7,22581%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,959 in reported general payments places this provider in the 80th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$277,847
Medicare patients
820
Services billed
3,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tavaborole231$145,206
JubliaEfinaconazole25$36,162
Oxiconazole Nitrate30$11,777
Ketoconazole121$3,382
Clotrimazole140$3,230
Ammonium Lactate24$465
Mupirocin30$412
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$289
Oxycodone Hcl42$260
Cephalexin39$252
Doxycycline Monohydrate27$238
Gabapentin25$189
Terbinafine Hcl26$185
Ondansetron OdtOndansetron11$102
Nabumetone11$101

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Baldwin

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →